Do "Consumer-Directed" health plans bend the cost curve over time?

Consumer-Directed" Health Plans (CDHPs), those with high deductibles and personal medical accounts, are intended to reduce health care spending through greater patient cost exposure. Prior research agrees that in the first year, CDHPs reduce spending. There is little research and in it results...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Haviland, Amelia M [verfasserIn] Eisenberg, Matthew D Mehrotra, Ateev Huckfeldt, Peter J Sood, Neeraj

Format:	Artikel
Sprache:	Englisch

Erschienen:	2016

Rechteinformationen:	Nutzungsrecht: Copyright © 2016 Elsevier B.V. All rights reserved.

Übergeordnetes Werk:	Enthalten in: Journal of health economics - Amsterdam [u.a.] : Elsevier, 1982, 46(2016), Seite 33
Übergeordnetes Werk:	volume:46 ; year:2016 ; pages:33

Links:	Volltext Link aufrufen

DOI / URN:	10.1016/j.jhealeco.2016.01.001

Katalog-ID:	OLC1973005670

Internformat


LEADER	01000caa a2200265 4500
001	OLC1973005670
003	DE-627
005	20211208214625.0
007	tu
008	160427s2016 xx \|\|\|\|\| 00\| \|\|eng c
024	7		\|a 10.1016/j.jhealeco.2016.01.001 \|2 doi
028	5	2	\|a PQ20160430
035			\|a (DE-627)OLC1973005670
035			\|a (DE-599)GBVOLC1973005670
035			\|a (PRQ)c1811-b506a0c1c7e3463f282da5edbea715fccdd3975121a685623f632e9511e6f5b20
035			\|a (KEY)0111907920160000046000000033doconsumerdirectedhealthplansbendthecostcurveovert
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 610 \|q DNB
100	1		\|a Haviland, Amelia M \|e verfasserin \|4 aut
245	1	0	\|a Do "Consumer-Directed" health plans bend the cost curve over time?
264		1	\|c 2016
336			\|a Text \|b txt \|2 rdacontent
337			\|a ohne Hilfsmittel zu benutzen \|b n \|2 rdamedia
338			\|a Band \|b nc \|2 rdacarrier
520			\|a Consumer-Directed" Health Plans (CDHPs), those with high deductibles and personal medical accounts, are intended to reduce health care spending through greater patient cost exposure. Prior research agrees that in the first year, CDHPs reduce spending. There is little research and in it results are mixed regarding the impact of CDHPs over the longer term. We add to this literature with an intent-to-treat, difference-in-differences analysis of health care spending over up to three years post CDHP offer among 13 million person-years of data from 54 large US firms, half of which offered CDHPs. To strengthen the identification, we balance observables over time within firm, by developing weights through a machine learning algorithm, generalized boosted regression. We find that spending is reduced for those in firms offering CDHPs in all three years post offer relative to firms continuing to offer lower-deductible plans. The reductions are driven by spending decreases in outpatient care and pharmaceuticals, with no evidence of increases in emergency department or inpatient care over the three-year window.
540			\|a Nutzungsrecht: Copyright © 2016 Elsevier B.V. All rights reserved.
700	1		\|a Eisenberg, Matthew D \|4 oth
700	1		\|a Mehrotra, Ateev \|4 oth
700	1		\|a Huckfeldt, Peter J \|4 oth
700	1		\|a Sood, Neeraj \|4 oth
773	0	8	\|i Enthalten in \|t Journal of health economics \|d Amsterdam [u.a.] : Elsevier, 1982 \|g 46(2016), Seite 33 \|w (DE-627)168045346 \|w (DE-600)625797-5 \|w (DE-576)015918297 \|x 0167-6296 \|7 nnns
773	1	8	\|g volume:46 \|g year:2016 \|g pages:33
856	4	1	\|u http://dx.doi.org/10.1016/j.jhealeco.2016.01.001 \|3 Volltext
856	4	2	\|u http://www.ncbi.nlm.nih.gov/pubmed/26851386
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a SSG-OLC-WIW
912			\|a GBV_ILN_26
912			\|a GBV_ILN_65
912			\|a GBV_ILN_70
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4311
951			\|a AR
952			\|d 46 \|j 2016 \|h 33

Indexfelder

author_variant	a m h am amh
matchkey_str	article:01676296:2016----::oosmrietdelhlnbnteo
hierarchy_sort_str	2016
publishDate	2016
allfields	10.1016/j.jhealeco.2016.01.001 doi PQ20160430 (DE-627)OLC1973005670 (DE-599)GBVOLC1973005670 (PRQ)c1811-b506a0c1c7e3463f282da5edbea715fccdd3975121a685623f632e9511e6f5b20 (KEY)0111907920160000046000000033doconsumerdirectedhealthplansbendthecostcurveovert DE-627 ger DE-627 rakwb eng 610 DNB Haviland, Amelia M verfasserin aut Do "Consumer-Directed" health plans bend the cost curve over time? 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Consumer-Directed" Health Plans (CDHPs), those with high deductibles and personal medical accounts, are intended to reduce health care spending through greater patient cost exposure. Prior research agrees that in the first year, CDHPs reduce spending. There is little research and in it results are mixed regarding the impact of CDHPs over the longer term. We add to this literature with an intent-to-treat, difference-in-differences analysis of health care spending over up to three years post CDHP offer among 13 million person-years of data from 54 large US firms, half of which offered CDHPs. To strengthen the identification, we balance observables over time within firm, by developing weights through a machine learning algorithm, generalized boosted regression. We find that spending is reduced for those in firms offering CDHPs in all three years post offer relative to firms continuing to offer lower-deductible plans. The reductions are driven by spending decreases in outpatient care and pharmaceuticals, with no evidence of increases in emergency department or inpatient care over the three-year window. Nutzungsrecht: Copyright © 2016 Elsevier B.V. All rights reserved. Eisenberg, Matthew D oth Mehrotra, Ateev oth Huckfeldt, Peter J oth Sood, Neeraj oth Enthalten in Journal of health economics Amsterdam [u.a.] : Elsevier, 1982 46(2016), Seite 33 (DE-627)168045346 (DE-600)625797-5 (DE-576)015918297 0167-6296 nnns volume:46 year:2016 pages:33 http://dx.doi.org/10.1016/j.jhealeco.2016.01.001 Volltext http://www.ncbi.nlm.nih.gov/pubmed/26851386 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-WIW GBV_ILN_26 GBV_ILN_65 GBV_ILN_70 GBV_ILN_4012 GBV_ILN_4311 AR 46 2016 33
spelling	10.1016/j.jhealeco.2016.01.001 doi PQ20160430 (DE-627)OLC1973005670 (DE-599)GBVOLC1973005670 (PRQ)c1811-b506a0c1c7e3463f282da5edbea715fccdd3975121a685623f632e9511e6f5b20 (KEY)0111907920160000046000000033doconsumerdirectedhealthplansbendthecostcurveovert DE-627 ger DE-627 rakwb eng 610 DNB Haviland, Amelia M verfasserin aut Do "Consumer-Directed" health plans bend the cost curve over time? 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Consumer-Directed" Health Plans (CDHPs), those with high deductibles and personal medical accounts, are intended to reduce health care spending through greater patient cost exposure. Prior research agrees that in the first year, CDHPs reduce spending. There is little research and in it results are mixed regarding the impact of CDHPs over the longer term. We add to this literature with an intent-to-treat, difference-in-differences analysis of health care spending over up to three years post CDHP offer among 13 million person-years of data from 54 large US firms, half of which offered CDHPs. To strengthen the identification, we balance observables over time within firm, by developing weights through a machine learning algorithm, generalized boosted regression. We find that spending is reduced for those in firms offering CDHPs in all three years post offer relative to firms continuing to offer lower-deductible plans. The reductions are driven by spending decreases in outpatient care and pharmaceuticals, with no evidence of increases in emergency department or inpatient care over the three-year window. Nutzungsrecht: Copyright © 2016 Elsevier B.V. All rights reserved. Eisenberg, Matthew D oth Mehrotra, Ateev oth Huckfeldt, Peter J oth Sood, Neeraj oth Enthalten in Journal of health economics Amsterdam [u.a.] : Elsevier, 1982 46(2016), Seite 33 (DE-627)168045346 (DE-600)625797-5 (DE-576)015918297 0167-6296 nnns volume:46 year:2016 pages:33 http://dx.doi.org/10.1016/j.jhealeco.2016.01.001 Volltext http://www.ncbi.nlm.nih.gov/pubmed/26851386 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-WIW GBV_ILN_26 GBV_ILN_65 GBV_ILN_70 GBV_ILN_4012 GBV_ILN_4311 AR 46 2016 33
allfields_unstemmed	10.1016/j.jhealeco.2016.01.001 doi PQ20160430 (DE-627)OLC1973005670 (DE-599)GBVOLC1973005670 (PRQ)c1811-b506a0c1c7e3463f282da5edbea715fccdd3975121a685623f632e9511e6f5b20 (KEY)0111907920160000046000000033doconsumerdirectedhealthplansbendthecostcurveovert DE-627 ger DE-627 rakwb eng 610 DNB Haviland, Amelia M verfasserin aut Do "Consumer-Directed" health plans bend the cost curve over time? 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Consumer-Directed" Health Plans (CDHPs), those with high deductibles and personal medical accounts, are intended to reduce health care spending through greater patient cost exposure. Prior research agrees that in the first year, CDHPs reduce spending. There is little research and in it results are mixed regarding the impact of CDHPs over the longer term. We add to this literature with an intent-to-treat, difference-in-differences analysis of health care spending over up to three years post CDHP offer among 13 million person-years of data from 54 large US firms, half of which offered CDHPs. To strengthen the identification, we balance observables over time within firm, by developing weights through a machine learning algorithm, generalized boosted regression. We find that spending is reduced for those in firms offering CDHPs in all three years post offer relative to firms continuing to offer lower-deductible plans. The reductions are driven by spending decreases in outpatient care and pharmaceuticals, with no evidence of increases in emergency department or inpatient care over the three-year window. Nutzungsrecht: Copyright © 2016 Elsevier B.V. All rights reserved. Eisenberg, Matthew D oth Mehrotra, Ateev oth Huckfeldt, Peter J oth Sood, Neeraj oth Enthalten in Journal of health economics Amsterdam [u.a.] : Elsevier, 1982 46(2016), Seite 33 (DE-627)168045346 (DE-600)625797-5 (DE-576)015918297 0167-6296 nnns volume:46 year:2016 pages:33 http://dx.doi.org/10.1016/j.jhealeco.2016.01.001 Volltext http://www.ncbi.nlm.nih.gov/pubmed/26851386 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-WIW GBV_ILN_26 GBV_ILN_65 GBV_ILN_70 GBV_ILN_4012 GBV_ILN_4311 AR 46 2016 33
allfieldsGer	10.1016/j.jhealeco.2016.01.001 doi PQ20160430 (DE-627)OLC1973005670 (DE-599)GBVOLC1973005670 (PRQ)c1811-b506a0c1c7e3463f282da5edbea715fccdd3975121a685623f632e9511e6f5b20 (KEY)0111907920160000046000000033doconsumerdirectedhealthplansbendthecostcurveovert DE-627 ger DE-627 rakwb eng 610 DNB Haviland, Amelia M verfasserin aut Do "Consumer-Directed" health plans bend the cost curve over time? 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Consumer-Directed" Health Plans (CDHPs), those with high deductibles and personal medical accounts, are intended to reduce health care spending through greater patient cost exposure. Prior research agrees that in the first year, CDHPs reduce spending. There is little research and in it results are mixed regarding the impact of CDHPs over the longer term. We add to this literature with an intent-to-treat, difference-in-differences analysis of health care spending over up to three years post CDHP offer among 13 million person-years of data from 54 large US firms, half of which offered CDHPs. To strengthen the identification, we balance observables over time within firm, by developing weights through a machine learning algorithm, generalized boosted regression. We find that spending is reduced for those in firms offering CDHPs in all three years post offer relative to firms continuing to offer lower-deductible plans. The reductions are driven by spending decreases in outpatient care and pharmaceuticals, with no evidence of increases in emergency department or inpatient care over the three-year window. Nutzungsrecht: Copyright © 2016 Elsevier B.V. All rights reserved. Eisenberg, Matthew D oth Mehrotra, Ateev oth Huckfeldt, Peter J oth Sood, Neeraj oth Enthalten in Journal of health economics Amsterdam [u.a.] : Elsevier, 1982 46(2016), Seite 33 (DE-627)168045346 (DE-600)625797-5 (DE-576)015918297 0167-6296 nnns volume:46 year:2016 pages:33 http://dx.doi.org/10.1016/j.jhealeco.2016.01.001 Volltext http://www.ncbi.nlm.nih.gov/pubmed/26851386 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-WIW GBV_ILN_26 GBV_ILN_65 GBV_ILN_70 GBV_ILN_4012 GBV_ILN_4311 AR 46 2016 33
allfieldsSound	10.1016/j.jhealeco.2016.01.001 doi PQ20160430 (DE-627)OLC1973005670 (DE-599)GBVOLC1973005670 (PRQ)c1811-b506a0c1c7e3463f282da5edbea715fccdd3975121a685623f632e9511e6f5b20 (KEY)0111907920160000046000000033doconsumerdirectedhealthplansbendthecostcurveovert DE-627 ger DE-627 rakwb eng 610 DNB Haviland, Amelia M verfasserin aut Do "Consumer-Directed" health plans bend the cost curve over time? 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Consumer-Directed" Health Plans (CDHPs), those with high deductibles and personal medical accounts, are intended to reduce health care spending through greater patient cost exposure. Prior research agrees that in the first year, CDHPs reduce spending. There is little research and in it results are mixed regarding the impact of CDHPs over the longer term. We add to this literature with an intent-to-treat, difference-in-differences analysis of health care spending over up to three years post CDHP offer among 13 million person-years of data from 54 large US firms, half of which offered CDHPs. To strengthen the identification, we balance observables over time within firm, by developing weights through a machine learning algorithm, generalized boosted regression. We find that spending is reduced for those in firms offering CDHPs in all three years post offer relative to firms continuing to offer lower-deductible plans. The reductions are driven by spending decreases in outpatient care and pharmaceuticals, with no evidence of increases in emergency department or inpatient care over the three-year window. Nutzungsrecht: Copyright © 2016 Elsevier B.V. All rights reserved. Eisenberg, Matthew D oth Mehrotra, Ateev oth Huckfeldt, Peter J oth Sood, Neeraj oth Enthalten in Journal of health economics Amsterdam [u.a.] : Elsevier, 1982 46(2016), Seite 33 (DE-627)168045346 (DE-600)625797-5 (DE-576)015918297 0167-6296 nnns volume:46 year:2016 pages:33 http://dx.doi.org/10.1016/j.jhealeco.2016.01.001 Volltext http://www.ncbi.nlm.nih.gov/pubmed/26851386 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-WIW GBV_ILN_26 GBV_ILN_65 GBV_ILN_70 GBV_ILN_4012 GBV_ILN_4311 AR 46 2016 33
language	English
source	Enthalten in Journal of health economics 46(2016), Seite 33 volume:46 year:2016 pages:33
sourceStr	Enthalten in Journal of health economics 46(2016), Seite 33 volume:46 year:2016 pages:33
format_phy_str_mv	Article
institution	findex.gbv.de
dewey-raw	610
isfreeaccess_bool	false
container_title	Journal of health economics
authorswithroles_txt_mv	Haviland, Amelia M @@aut@@ Eisenberg, Matthew D @@oth@@ Mehrotra, Ateev @@oth@@ Huckfeldt, Peter J @@oth@@ Sood, Neeraj @@oth@@
publishDateDaySort_date	2016-01-01T00:00:00Z
hierarchy_top_id	168045346
dewey-sort	3610
id	OLC1973005670
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1973005670</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20211208214625.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">160427s2016 xx \|\|\|\|\| 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jhealeco.2016.01.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20160430</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1973005670</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1973005670</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)c1811-b506a0c1c7e3463f282da5edbea715fccdd3975121a685623f632e9511e6f5b20</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0111907920160000046000000033doconsumerdirectedhealthplansbendthecostcurveovert</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DNB</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Haviland, Amelia M</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Do "Consumer-Directed" health plans bend the cost curve over time?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Consumer-Directed" Health Plans (CDHPs), those with high deductibles and personal medical accounts, are intended to reduce health care spending through greater patient cost exposure. Prior research agrees that in the first year, CDHPs reduce spending. There is little research and in it results are mixed regarding the impact of CDHPs over the longer term. We add to this literature with an intent-to-treat, difference-in-differences analysis of health care spending over up to three years post CDHP offer among 13 million person-years of data from 54 large US firms, half of which offered CDHPs. To strengthen the identification, we balance observables over time within firm, by developing weights through a machine learning algorithm, generalized boosted regression. We find that spending is reduced for those in firms offering CDHPs in all three years post offer relative to firms continuing to offer lower-deductible plans. The reductions are driven by spending decreases in outpatient care and pharmaceuticals, with no evidence of increases in emergency department or inpatient care over the three-year window.</subfield></datafield><datafield tag="540" ind1=" " ind2=" "><subfield code="a">Nutzungsrecht: Copyright © 2016 Elsevier B.V. All rights reserved.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eisenberg, Matthew D</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mehrotra, Ateev</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huckfeldt, Peter J</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sood, Neeraj</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Journal of health economics</subfield><subfield code="d">Amsterdam [u.a.] : Elsevier, 1982</subfield><subfield code="g">46(2016), Seite 33</subfield><subfield code="w">(DE-627)168045346</subfield><subfield code="w">(DE-600)625797-5</subfield><subfield code="w">(DE-576)015918297</subfield><subfield code="x">0167-6296</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:46</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:33</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://dx.doi.org/10.1016/j.jhealeco.2016.01.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://www.ncbi.nlm.nih.gov/pubmed/26851386</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-WIW</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_26</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4311</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">46</subfield><subfield code="j">2016</subfield><subfield code="h">33</subfield></datafield></record></collection>
author	Haviland, Amelia M
spellingShingle	Haviland, Amelia M ddc 610 Do "Consumer-Directed" health plans bend the cost curve over time?
authorStr	Haviland, Amelia M
ppnlink_with_tag_str_mv	@@773@@(DE-627)168045346
format	Article
dewey-ones	610 - Medicine & health
delete_txt_mv	keep
author_role	aut
collection	OLC
remote_str	false
illustrated	Not Illustrated
issn	0167-6296
topic_title	610 DNB Do "Consumer-Directed" health plans bend the cost curve over time?
topic	ddc 610
topic_unstemmed	ddc 610
topic_browse	ddc 610
format_facet	Aufsätze Gedruckte Aufsätze
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	nc
author2_variant	m d e md mde a m am p j h pj pjh n s ns
hierarchy_parent_title	Journal of health economics
hierarchy_parent_id	168045346
dewey-tens	610 - Medicine & health
hierarchy_top_title	Journal of health economics
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)168045346 (DE-600)625797-5 (DE-576)015918297
title	Do "Consumer-Directed" health plans bend the cost curve over time?
ctrlnum	(DE-627)OLC1973005670 (DE-599)GBVOLC1973005670 (PRQ)c1811-b506a0c1c7e3463f282da5edbea715fccdd3975121a685623f632e9511e6f5b20 (KEY)0111907920160000046000000033doconsumerdirectedhealthplansbendthecostcurveovert
title_full	Do "Consumer-Directed" health plans bend the cost curve over time?
author_sort	Haviland, Amelia M
journal	Journal of health economics
journalStr	Journal of health economics
lang_code	eng
isOA_bool	false
dewey-hundreds	600 - Technology
recordtype	marc
publishDateSort	2016
contenttype_str_mv	txt
container_start_page	33
author_browse	Haviland, Amelia M
container_volume	46
class	610 DNB
format_se	Aufsätze
author-letter	Haviland, Amelia M
doi_str_mv	10.1016/j.jhealeco.2016.01.001
dewey-full	610
title_sort	do "consumer-directed" health plans bend the cost curve over time?
title_auth	Do "Consumer-Directed" health plans bend the cost curve over time?
abstract	Consumer-Directed" Health Plans (CDHPs), those with high deductibles and personal medical accounts, are intended to reduce health care spending through greater patient cost exposure. Prior research agrees that in the first year, CDHPs reduce spending. There is little research and in it results are mixed regarding the impact of CDHPs over the longer term. We add to this literature with an intent-to-treat, difference-in-differences analysis of health care spending over up to three years post CDHP offer among 13 million person-years of data from 54 large US firms, half of which offered CDHPs. To strengthen the identification, we balance observables over time within firm, by developing weights through a machine learning algorithm, generalized boosted regression. We find that spending is reduced for those in firms offering CDHPs in all three years post offer relative to firms continuing to offer lower-deductible plans. The reductions are driven by spending decreases in outpatient care and pharmaceuticals, with no evidence of increases in emergency department or inpatient care over the three-year window.
abstractGer	Consumer-Directed" Health Plans (CDHPs), those with high deductibles and personal medical accounts, are intended to reduce health care spending through greater patient cost exposure. Prior research agrees that in the first year, CDHPs reduce spending. There is little research and in it results are mixed regarding the impact of CDHPs over the longer term. We add to this literature with an intent-to-treat, difference-in-differences analysis of health care spending over up to three years post CDHP offer among 13 million person-years of data from 54 large US firms, half of which offered CDHPs. To strengthen the identification, we balance observables over time within firm, by developing weights through a machine learning algorithm, generalized boosted regression. We find that spending is reduced for those in firms offering CDHPs in all three years post offer relative to firms continuing to offer lower-deductible plans. The reductions are driven by spending decreases in outpatient care and pharmaceuticals, with no evidence of increases in emergency department or inpatient care over the three-year window.
abstract_unstemmed	Consumer-Directed" Health Plans (CDHPs), those with high deductibles and personal medical accounts, are intended to reduce health care spending through greater patient cost exposure. Prior research agrees that in the first year, CDHPs reduce spending. There is little research and in it results are mixed regarding the impact of CDHPs over the longer term. We add to this literature with an intent-to-treat, difference-in-differences analysis of health care spending over up to three years post CDHP offer among 13 million person-years of data from 54 large US firms, half of which offered CDHPs. To strengthen the identification, we balance observables over time within firm, by developing weights through a machine learning algorithm, generalized boosted regression. We find that spending is reduced for those in firms offering CDHPs in all three years post offer relative to firms continuing to offer lower-deductible plans. The reductions are driven by spending decreases in outpatient care and pharmaceuticals, with no evidence of increases in emergency department or inpatient care over the three-year window.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-WIW GBV_ILN_26 GBV_ILN_65 GBV_ILN_70 GBV_ILN_4012 GBV_ILN_4311
title_short	Do "Consumer-Directed" health plans bend the cost curve over time?
url	http://dx.doi.org/10.1016/j.jhealeco.2016.01.001 http://www.ncbi.nlm.nih.gov/pubmed/26851386
remote_bool	false
author2	Eisenberg, Matthew D Mehrotra, Ateev Huckfeldt, Peter J Sood, Neeraj
author2Str	Eisenberg, Matthew D Mehrotra, Ateev Huckfeldt, Peter J Sood, Neeraj
ppnlink	168045346
mediatype_str_mv	n
isOA_txt	false
hochschulschrift_bool	false
author2_role	oth oth oth oth
doi_str	10.1016/j.jhealeco.2016.01.001
up_date	2024-07-04T01:20:12.493Z
_version_	1803609453357957120
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1973005670</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20211208214625.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">160427s2016 xx \|\|\|\|\| 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jhealeco.2016.01.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20160430</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1973005670</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1973005670</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)c1811-b506a0c1c7e3463f282da5edbea715fccdd3975121a685623f632e9511e6f5b20</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0111907920160000046000000033doconsumerdirectedhealthplansbendthecostcurveovert</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DNB</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Haviland, Amelia M</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Do "Consumer-Directed" health plans bend the cost curve over time?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Consumer-Directed" Health Plans (CDHPs), those with high deductibles and personal medical accounts, are intended to reduce health care spending through greater patient cost exposure. Prior research agrees that in the first year, CDHPs reduce spending. There is little research and in it results are mixed regarding the impact of CDHPs over the longer term. We add to this literature with an intent-to-treat, difference-in-differences analysis of health care spending over up to three years post CDHP offer among 13 million person-years of data from 54 large US firms, half of which offered CDHPs. To strengthen the identification, we balance observables over time within firm, by developing weights through a machine learning algorithm, generalized boosted regression. We find that spending is reduced for those in firms offering CDHPs in all three years post offer relative to firms continuing to offer lower-deductible plans. The reductions are driven by spending decreases in outpatient care and pharmaceuticals, with no evidence of increases in emergency department or inpatient care over the three-year window.</subfield></datafield><datafield tag="540" ind1=" " ind2=" "><subfield code="a">Nutzungsrecht: Copyright © 2016 Elsevier B.V. All rights reserved.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eisenberg, Matthew D</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mehrotra, Ateev</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huckfeldt, Peter J</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sood, Neeraj</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Journal of health economics</subfield><subfield code="d">Amsterdam [u.a.] : Elsevier, 1982</subfield><subfield code="g">46(2016), Seite 33</subfield><subfield code="w">(DE-627)168045346</subfield><subfield code="w">(DE-600)625797-5</subfield><subfield code="w">(DE-576)015918297</subfield><subfield code="x">0167-6296</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:46</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:33</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://dx.doi.org/10.1016/j.jhealeco.2016.01.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://www.ncbi.nlm.nih.gov/pubmed/26851386</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-WIW</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_26</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4311</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">46</subfield><subfield code="j">2016</subfield><subfield code="h">33</subfield></datafield></record></collection>
score	7.4014883

Nicht das Richtige dabei?

Schreiben Sie uns!

Do "Consumer-Directed" health plans bend the cost curve over time?

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?